Irritable bowel syndrome: epidemiology/economic burden
Irritable bowel syndrome: epidemiology/economic burden
复制标题
DOI：
10.1016/s0399-8320(09)71519-2
复制
发表时间：
2009-02-01
影响因子：
--
通讯作者：
Dapoigny, M.
中科院分区：
文献类型：
--
作者：
Dapoigny, M.
肠易激综合征（IBS）的患病率无论在哪里评估都很高。IBS的定义仍有争议，但工业化国家的IBS患者的特征非常相似。由于缺乏明确的生物学标志物，需要进行许多补充检查。IBS的诊断仍然是一种排除诊断，尽管罗马标准的出版，它已试图推进到一个积极的诊断。腹痛或不适是主要症状，也是咨询的主要原因。IBS患者的生活质量受损，并且与症状严重程度明显相关。所有这些观点至少部分解释了IBS对医疗资源的经济负担。IBS的成本很难评估，因为它的组成部分不同：直接成本，如医疗咨询的数量，药物消耗以及补充调查的数量和质量比间接成本，如工作缺勤或改变出勤率，更容易评估，这可能对IBS的成本产生重大影响。(C)2009年Elsevier Masson SAS。All rights reserved.
The prevalence of irritable bowel syndrome (IBS) is high wherever it is assessed. The definition is still controversial, but the IBS patient's characteristics are quite similar in industrialized countries. The lack of a definite biological marker results in the prescription of many complementary examinations. The diagnosis of IBS remains an elimination diagnosis, despite the publication of the Rome criteria, which has attempted to advance toward a positive diagnosis. Abdominal pain or discomfort are the main symptoms and are the major reasons for consulting. The quality of life is impaired in IBS and is clearly correlated with symptom severity. All these points at least partially explain the economic burden of IBS on health care resources. The cost of IBS is difficult to assess because of its different components: the direct costs such as the number of medical consultations, drug consumption, and the number and quality of complementary investigations are easier to evaluate than the indirect costs such as work absenteeism or altered presenteeism, which can have a major impact on the cost of IBS. (C) 2009 Elsevier Masson SAS. All rights reserved.